SLC2A14 (or GLUT14) expression is deregulated in several cancer types and is suggested to be a prognostic factor for a number of cancers, for example, in thyroid carcinoma (Chai et al. 2017). Here, SLC2A14 is linked to thyroid gland carcinoma.